<?xml version="1.0" encoding="UTF-8"?>
<p>IDSA and HIVMA supported the SUPPORT Act, including provisions that improved Medicaid and Medicare coverage of SUD treatment and services, and that increased the patient cap for which physicians could prescribe MOUD. Priority issues for IDSA and HIVMA were provisions authorizing funding for the Centers for Disease Control and Prevention (CDC) to eliminate opioid related infections through improved surveillance and prevention for infections linked to IDU and funding for the Health Resources and Services Administration to build workforce capacity through a new Substance Use Treatment Provider Loan Forgiveness Program, offering up to $250 000 in loan repayment over 6 years for providers working in substance use treatment facilities [
 <xref rid="CIT0020" ref-type="bibr">20</xref>]. Both programs depend on Congress to appropriate funding. Five million dollars was appropriated for fiscal year 2019 for the CDC Eliminate Opioid Related Infections funding provision. The fiscal year 2020 appropriations bills were signed into law on December 20, 2019 and included $10 million for the CDCâ€™s Eliminate Opioid Related Infections program and $12 million for the new substance use disorder loan forgiveness program [
 <xref rid="CIT0021" ref-type="bibr">21</xref>].
</p>
